James J Schutz - Net Worth and Insider Trading

James J Schutz Net Worth

The estimated net worth of James J Schutz is at least $601 dollars as of 2024-11-12. James J Schutz is the CEO of Sonoma Pharmaceuticals Inc and owns about 199 shares of Sonoma Pharmaceuticals Inc (SNOA) stock worth over $601. Details can be seen in James J Schutz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James J Schutz has not made any transactions after 2018-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James J Schutz

To

James J Schutz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James J Schutz owns 1 companies in total, including Sonoma Pharmaceuticals Inc (SNOA) .

Click here to see the complete history of James J Schutz’s form 4 insider trades.

Insider Ownership Summary of James J Schutz

Ticker Comapny Transaction Date Type of Owner
SNOA Sonoma Pharmaceuticals Inc 2018-03-08 director & Chief Operating Officer

James J Schutz Latest Holdings Summary

James J Schutz currently owns a total of 1 stock. James J Schutz owns 199 shares of Sonoma Pharmaceuticals Inc (SNOA) as of March 8, 2018, with a value of $601.

Latest Holdings of James J Schutz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SNOA Sonoma Pharmaceuticals Inc 2018-03-08 199 3.02 601

Holding Weightings of James J Schutz


James J Schutz Form 4 Trading Tracker

According to the SEC Form 4 filings, James J Schutz has made a total of 0 transactions in Sonoma Pharmaceuticals Inc (SNOA) over the past 5 years. The most-recent trade in Sonoma Pharmaceuticals Inc is the acquisition of 14 shares on March 8, 2018, which cost James J Schutz around $9,867.

Insider Trading History of James J Schutz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James J Schutz Trading Performance

GuruFocus tracks the stock performance after each of James J Schutz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James J Schutz is -4.65%. GuruFocus also compares James J Schutz's trading performance to market benchmark return within the same time period. The performance of stocks bought by James J Schutz within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James J Schutz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James J Schutz

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.64 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.31 LIMIT LIMIT LIMIT LIMIT LIMIT

James J Schutz Ownership Network

Ownership Network List of James J Schutz

No Data

Ownership Network Relation of James J Schutz

Insider Network Chart

James J Schutz Owned Company Details

What does Sonoma Pharmaceuticals Inc do?

Who are the key executives at Sonoma Pharmaceuticals Inc?

James J Schutz is the director & Chief Operating Officer of Sonoma Pharmaceuticals Inc. Other key executives at Sonoma Pharmaceuticals Inc include Interim CFO Chad Norman White , Chief Financial Officer Jerome J Dvonch , and Chief Financial Officer Robert Grant Edwards .

Sonoma Pharmaceuticals Inc (SNOA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sonoma Pharmaceuticals Inc (SNOA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonoma Pharmaceuticals Inc (SNOA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sonoma Pharmaceuticals Inc (SNOA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sonoma Pharmaceuticals Inc Insider Transactions

No Available Data

James J Schutz Mailing Address

Above is the net worth, insider trading, and ownership report for James J Schutz. You might contact James J Schutz via mailing address: 1129 N. Mcdowell Blvd., Petaluma Ca 94954.